Top Institutions in Ophthalmology
Leading academic ophthalmology centers conduct multicenter clinical trials and subgroup analyses to evaluate novel formulations and dosing regimens of immunomodulatory therapies like cyclosporine for dry eye disease, emphasizing corneal staining and symptom assessment endpoints.
-
#1
Wilmer Eye Institute, Johns Hopkins University
Baltimore, MD
Wilmer Eye Institute is a world leader in corneal and ocular surface disease research, with extensive clinical trials in dry eye therapies including cyclosporine formulations. Their faculty, including Dr. Michelle M. Hessen, actively contribute to advancing treatment paradigms.
-
#2
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Massachusetts Eye and Ear is a top-ranked ophthalmology center with a strong focus on dry eye disease and ocular surface inflammation, conducting numerous clinical trials on cyclosporine and other dry eye treatments.
-
#3
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer Eye Institute is internationally recognized for its clinical and translational research in dry eye disease and ocular surface disorders, with a strong track record in evaluating immunomodulatory therapies.
-
#4
Duke Eye Center, Duke University
Durham, NC
Duke Eye Center has a robust research program in ocular surface disease and dry eye, contributing to clinical trials and mechanistic studies of cyclosporine and other immunomodulatory agents.